Assessment of the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Clinical trial NCT04408755 · TERMINATED
Trial details
- NCT number
- NCT04408755
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-13
- Primary completion
- 2024-06-27
- Enrollment
- 184
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.